Your browser is no longer supported. Please, upgrade your browser.
Settings
ENZ Enzo Biochem, Inc. daily Stock Chart
ENZ [NYSE]
Enzo Biochem, Inc.
Index- P/E131.25 EPS (ttm)0.02 Insider Own7.71% Shs Outstand46.71M Perf Week-4.98%
Market Cap98.09M Forward P/E- EPS next Y- Insider Trans0.28% Shs Float43.90M Perf Month-14.63%
Income0.80M PEG- EPS next Q- Inst Own68.60% Short Float2.37% Perf Quarter-24.73%
Sales80.10M P/S1.22 EPS this Y121.60% Inst Trans-1.24% Short Ratio10.09 Perf Half Y-30.92%
Book/sh1.65 P/B1.27 EPS next Y- ROA0.80% Target Price5.50 Perf Year-40.17%
Cash/sh1.22 P/C1.72 EPS next 5Y- ROE1.00% 52W Range2.08 - 4.46 Perf YTD-20.15%
Dividend- P/FCF108.99 EPS past 5Y17.30% ROI1.90% 52W High-54.26% Beta1.00
Dividend %- Quick Ratio3.00 Sales past 5Y-3.30% Gross Margin27.40% 52W Low-1.92% ATR0.15
Employees460 Current Ratio3.40 Sales Q/Q-5.20% Oper. Margin-0.60% RSI (14)34.84 Volatility8.86% 6.37%
OptionableYes Debt/Eq0.06 EPS Q/Q-26.90% Profit Margin1.00% Rel Volume0.79 Prev Close2.10
ShortableYes LT Debt/Eq0.06 EarningsMar 09 AMC Payout0.00% Avg Volume103.04K Price2.04
Recom- SMA20-13.12% SMA50-18.18% SMA200-35.48% Volume62,425 Change-2.86%
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
Feb-25-20 10:27AM  Shareholders Support the Election of Both HDF Nominees to Enzo Board of Directors Business Wire +9.09%
09:59AM  Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting Business Wire
Feb-19-20 05:16PM  ISS Recommends Shareholders Vote AGAINST Enzo Proposal to Increase Size of Board Business Wire
08:30AM  Enzo Biochem Reports Publication of Study Detailing Promising Activity of Drug Candidate SK1I in a Model of Lupus Business Wire
Feb-12-20 09:18AM  The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga
Feb-11-20 08:30AM  Enzo Biochem Announces Significant Milestone with Approval of Proprietary GenFlex Platform Business Wire
Feb-07-20 08:00AM  Enzo Disappointed in Harberts Lawsuit Aimed at Disenfranchising Shareholders Business Wire
Feb-06-20 03:07PM  Harbert Discovery Fund Files Lawsuit Seeking to Hold Enzo Board Accountable for Acts of Entrenchment and Illegal Maneuvers Business Wire
Jan-30-20 08:13AM  Enzo Comments on Harberts Reaction to Providing Enzo Shareholders Additional Choices Business Wire
Jan-29-20 10:51AM  Harbert Discovery Fund Comments on Enzo Biochems Entrenchment Maneuvers Business Wire
Jan-28-20 05:45PM  Enzo Biochem Proposes to Increase Size of Board and Will Appoint Additional Highly Qualified, Diverse Independent Director in Near Future Business Wire
Jan-27-20 06:45AM  Harbert Discovery Fund Sends Letter to Fellow Enzo Biochem Shareholders Business Wire
Jan-21-20 02:36PM  All Three Proxy Advisory Firms Recommend Shareholders Vote FOR Change to the Board of Enzo Biochem on the Blue Card Business Wire
Jan-17-20 03:02PM  Enzo Biochem Comments on ISS Report Business Wire
11:56AM  ISS Recommends Shareholders Vote FOR the Election of Harbert Discovery Fund Nominee to Enzo Biochem Board Business Wire
Jan-16-20 01:03PM  Glass Lewis Recommends Shareholders Vote For the Election of Both Harbert Discovery Fund Nominees to Enzo Biochems Board Business Wire +5.84%
Jan-13-20 08:00AM  Enzo Biochem Responds to Series of Misleading and Inaccurate Statements from Activist Hedge Fund Harbert Business Wire
Jan-08-20 09:00AM  Harbert Discovery Fund Releases Detailed Investor Presentation Highlighting Case for Change at Enzo Biochem Business Wire
08:49AM  How Does Enzo Biochem, Inc. (NYSE:ENZ) Affect Your Portfolio Volatility? Simply Wall St.
Dec-31-19 10:48AM  Enzo Biochem Appoints Rebecca J. Fischer to Board of Directors Business Wire
Dec-30-19 09:00AM  Harbert Discovery Fund Sends Letter to Fellow Enzo Biochem Shareholders Business Wire
Dec-14-19 07:01PM  Is Enzo Biochem, Inc. (ENZ) Going To Burn These Hedge Funds ? Insider Monkey
Dec-10-19 04:15PM  Enzo Biochem Reports Fiscal First Quarter Results Business Wire +8.78%
Dec-05-19 04:15PM  Enzo Biochem Issues Open Letter to Shareholders Business Wire
12:00PM  Enzo Biochem Schedules Teleconference to Discuss First Quarter 2020 Results Tuesday, December 10, 2019 At 4:30 PM E.T. Business Wire
Nov-09-19 09:18AM  What Kind Of Shareholders Own Enzo Biochem, Inc. (NYSE:ENZ)? Simply Wall St.
Oct-17-19 08:44PM  Edited Transcript of ENZ earnings conference call or presentation 15-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
Oct-15-19 04:15PM  Enzo Biochem Reports Fiscal Fourth Quarter and Full Year Financial Results Business Wire
Oct-11-19 09:00AM  Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal Year 2019 Results Tuesday, October 15, 2019 at 4:30 PM E.T. Business Wire +5.17%
Oct-10-19 08:06AM  Does Enzo Biochem, Inc.'s (NYSE:ENZ) CEO Salary Reflect Performance? Simply Wall St.
Sep-24-19 09:00AM  New York State Health Department Approves Hepatitis B Virus Quantitative Clinical Assay Business Wire
Sep-17-19 09:00AM  Harbert Discovery Fund Nominates Two Highly-Qualified Independent Candidates to Enzo Biochem Board Business Wire
Sep-10-19 07:33AM  Investors Who Bought Enzo Biochem (NYSE:ENZ) Shares Five Years Ago Are Now Down 41% Simply Wall St.
Aug-15-19 07:43AM  Is Enzo Biochem (NYSE:ENZ) Using Debt In A Risky Way? Simply Wall St. -9.12%
Aug-05-19 09:00AM  Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications Business Wire -7.69%
Jul-17-19 10:48AM  Is Enzo Biochem, Inc.'s (NYSE:ENZ) 2.3% ROE Worse Than Average? Simply Wall St.
Jul-11-19 09:00AM  Enzo Biochem Announces Key Transformative Initiatives to Propel and Accelerate Growth In its Lab Business Business Wire
Jul-02-19 07:12PM  Edited Transcript of ENZ earnings conference call or presentation 11-Jun-19 12:30pm GMT Thomson Reuters StreetEvents
Jun-11-19 02:54PM  What Kind Of Share Price Volatility Should You Expect For Enzo Biochem, Inc. (NYSE:ENZ)? Simply Wall St. +13.07%
06:30AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Jun-10-19 04:17PM  Enzo Biochem Reports Fiscal Third Quarter and Nine Months Operating Results Business Wire
Jun-05-19 09:00AM  Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2019 Results Tuesday, June 11, 2019 at 8:30 AM E.T. Business Wire
May-10-19 10:48AM  Enzo Biochem Inc. Announces Issuance of United States Patent for Treatment of Liver Cancer Using Ozanimod Business Wire
May-02-19 06:00AM  Biotech Bets and a Goodbye from a Favorite Expert MoneyShow
Apr-23-19 02:19PM  What Percentage Of Enzo Biochem, Inc. (NYSE:ENZ) Shares Do Insiders Own? Simply Wall St.
Apr-01-19 06:25PM  Edited Transcript of ENZ earnings conference call or presentation 12-Mar-19 12:30pm GMT Thomson Reuters StreetEvents
Mar-11-19 04:50PM  Enzo Biochem: Fiscal 2Q Earnings Snapshot Associated Press
04:10PM  Enzo Biochem Reports Second Fiscal Quarter and First Half 2019 Results and Reports Progress on Its Investments and Strategic Goals Business Wire
Mar-05-19 04:05PM  Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2019 Results Tuesday, March 12, 2019 at 8:30 AM E.T. Business Wire
Feb-26-19 12:45PM  Why Enzo Biochem, Inc.s (NYSE:ENZ) CEO Pay Matters To You Simply Wall St.
Jan-29-19 07:35AM  Factors of Influence in 2019, Key Indicators and Opportunity within The Hain Celestial Group, Allegheny Technologies, NVR, Greif, CorMedix, and Enzo Biochem New Research Emphasizes Economic Growth GlobeNewswire
Jan-06-19 11:36PM  Edited Transcript of ENZ earnings conference call or presentation 11-Dec-18 1:30pm GMT Thomson Reuters StreetEvents
Jan-02-19 01:40PM  How Many Insiders Bought Enzo Biochem, Inc. (NYSE:ENZ) Shares? Simply Wall St.
Dec-10-18 04:21PM  Enzo Biochem: Fiscal 1Q Earnings Snapshot Associated Press
04:15PM  Enzo Biochem Reports Fiscal 2019 First Quarter Results Business Wire
Dec-06-18 09:00AM  Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T. Business Wire +9.73%
Dec-03-18 09:00AM  Enzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast Cancer Business Wire
Nov-14-18 12:57PM  What Kind Of Shareholder Owns Most Enzo Biochem Inc (NYSE:ENZ) Stock? Simply Wall St.
Oct-29-18 08:25AM  Market Trends Toward New Normal in Polaris Industries, NIKE, Charles River Laboratories International, Actuant, Caesarstone, and Enzo Biochem Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-17-18 08:15AM  The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise Benzinga
Oct-16-18 09:42PM  Edited Transcript of ENZ earnings conference call or presentation 16-Oct-18 12:30pm GMT Thomson Reuters StreetEvents -5.33%
08:52AM  The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist Benzinga
06:30AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Oct-15-18 04:20PM  Enzo Biochem: Fiscal 4Q Earnings Snapshot Associated Press
04:05PM  Enzo Biochem Reports Fourth Quarter and Fiscal 2018 Results Business Wire
Oct-11-18 12:49PM  Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T. Business Wire
Oct-03-18 07:33PM  Top 5 Biotech Stocks for 2018 Investopedia +7.14%
Aug-27-18 08:30AM  Enzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy Business Wire
Aug-02-18 08:15AM  Market Trends Toward New Normal in Sandy Spring, Tupperware Brands, Dolby Laboratories, AeroVironment, Barnes Group, and Enzo Biochem Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-18-18 09:00AM  Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their Progression, Especially in Womens Health Area Business Wire
Jul-06-18 07:10AM  Blog Exposure - Bruker Buys Dutch Milk Analysis Equipment Manufacturer Lactotronic to Expand its Presence in the Dairy Industry ACCESSWIRE
Jun-13-18 06:03AM  Edited Transcript of ENZ earnings conference call or presentation 12-Jun-18 12:30pm GMT Thomson Reuters StreetEvents
Jun-12-18 08:47AM  Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate Benzinga -8.96%
Jun-11-18 04:21PM  Enzo Biochem: Fiscal 3Q Earnings Snapshot Associated Press
04:10PM  Enzo Biochem Reports Third Quarter Results Business Wire
Jun-06-18 10:00AM  Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 at 8:30 AM E.T. Business Wire
Apr-24-18 10:00AM  Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case Business Wire
Mar-14-18 03:58AM  Edited Transcript of ENZ earnings conference call or presentation 13-Mar-18 12:30pm GMT Thomson Reuters StreetEvents
Mar-13-18 08:04AM  Earnings Outlook For Enzo Biochem Benzinga -6.82%
06:45AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Mar-12-18 04:29PM  Enzo Biochem reports 2Q loss Associated Press
04:05PM  Enzo Biochem Reports Second Quarter and First Half Results Business Wire
Mar-08-18 04:10PM  Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 at 8:30 AM E.T. Business Wire
Feb-26-18 07:30AM  Exploring Fundamental Drivers Behind Enzo Biochem, RPX, The Hackett Group, 2U, AK Steel Holding, and Och-Ziff Capital Management Group New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-22-18 09:00AM  Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test Business Wire
Jan-09-18 07:00AM  Free Post Earnings Research Report: Enzo Biochems Revenue Grew 5%; Net Loss Narrowed ACCESSWIRE
Dec-19-17 07:50AM  Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Dec-13-17 07:00AM  Blog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell Lymphomas ACCESSWIRE
Dec-11-17 04:53PM  Edited Transcript of ENZ earnings conference call or presentation 8-Dec-17 1:30pm GMT Thomson Reuters StreetEvents
02:46PM  Enzo Biochem (ENZ) Q1 2018 Earnings Conference Call Transcript Motley Fool
10:40AM  Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q1, 2018 By the Numbers : December 11, 2017 Capital Cube
Dec-08-17 07:00AM  Enzo Biochem, Inc. to Host Earnings Call ACCESSWIRE
Dec-07-17 04:15PM  Enzo Biochem reports 1Q loss Associated Press
04:10PM  Enzo Biochem Reports Improved First Quarter Results Business Wire
01:39PM  ETFs with exposure to Enzo Biochem, Inc. : December 7, 2017 Capital Cube
Dec-05-17 08:00AM  Enzo Biochem Schedules Teleconference to Discuss First Quarter 2018 Results Friday, December 8, 2017 at 8:30 AM E.T. Business Wire
Oct-24-17 09:37AM  ETFs with exposure to Enzo Biochem, Inc. : October 24, 2017 Capital Cube
Oct-23-17 08:30AM  Enzo Biochem Announces NYS Department of Healths Approval of a New Womens Health Infectious Disease Panel Business Wire
Oct-21-17 06:16PM  What Investors Should Know About Enzo Biochem Incs (ENZ) Financial Strength Simply Wall St.
Oct-13-17 10:45AM  ETFs with exposure to Enzo Biochem, Inc. : October 13, 2017 Capital Cube
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates in Life Sciences Products, Clinical Laboratory Services, and Therapeutics segments. The Life Sciences Products segment manufactures, develops, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, or search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 34 patient service centers in New York and New Jersey; and a free standing 'STAT' or rapid response laboratory in New York City and Connecticut, as well as a full-service phlebotomy department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CLEMENS PETER J IV10% OwnerFeb 18Buy2.204,0008,80015,000Feb 19 02:45 PM
CLEMENS PETER J IV10% OwnerFeb 14Buy2.216,00013,26011,000Feb 19 02:45 PM
HARBERT MANAGEMENT CORP10% OwnerAug 20Buy3.119,70030,1675,620,681Aug 20 05:44 PM
HARBERT MANAGEMENT CORP10% OwnerAug 16Buy3.0622,80069,7685,610,981Aug 20 05:44 PM
HARBERT MANAGEMENT CORP10% OwnerJul 23Buy3.65409,2001,493,5805,588,181Jul 24 12:21 PM
HARBERT MANAGEMENT CORP10% OwnerJul 22Buy3.649,64435,1045,178,981Jul 24 12:21 PM
HARBERT MANAGEMENT CORP10% OwnerMay 30Buy3.0719,39159,5305,169,337May 30 05:20 PM
HARBERT MANAGEMENT CORP10% OwnerMay 29Buy3.0819,05058,6745,149,946May 30 05:20 PM
HARBERT MANAGEMENT CORP10% OwnerMay 28Buy3.0963,677196,8525,130,896May 30 05:20 PM
HARBERT MANAGEMENT CORP10% OwnerMay 20Buy3.6114,13251,0175,067,219May 22 04:49 PM